OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.07−0.09 (-7.76%)
Close on Nov 20, 2026Market cap $56.15MP/E –Yield –
OKYO Pharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for OKYO Pharma
OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?